Edison issues research note on the Company

RNS Number : 4380G

Intl. Biotechnology Trust PLC

03 March 2015

 



International Biotechnology Trust plc ("IBT")

Edison issues research note on the Company

Now in its 21st year, IBT is a specialist investor in biotechnology companies globally. In the year ended February 2015, it returned c 50% in NAV and 49% in share price terms, ahead of the Nasdaq Biotechnology Index's 39% return. IBT is differentiated from its peers by its holdings in unquoted stocks (c 8% at present), a part of the portfolio that has recently contributed to the Trust's strong performance, reflecting successful exits and a milestone payment. The long-term growth drivers for the biotech sector remain in place and the Investment Managers expect strong sector earnings growth to outpace market growth over the long-term.

For the full report click on the following link:

http://www.edisoninvestmentresearch.com/research/report/international-biotechnology-trust7

All reports published by Edison are available to download free of charge from its website.

www.edisoninvestmentresearch.com

Susan Gledhill

For and on behalf of

BNP Paribas Secretarial Services Limited

Company Secretary

Telephone:  [phone]

3 MARCH 2015

 

END

 

 

NRAPKNDKABKDDNK